Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk November 5, 2021 Disclosures: TBD
Dr. Nicolas Van Mieghem and Dr. Yaz Dabboul Discuss: SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk November 5, 2021 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: TCT 2021 Daily Wrap-Up – November 4, 2021 November 4, 2021 Disclosures: TBA
Dr. David Cohen and Dr. C. Michael Gibson Discuss: Going with the Flow November 4, 2021 Disclosures: TBA
Dr. Dipti Itchhaporia and Dr. C. Michael Gibson Discuss: ACC and the Digital Transformation November 4, 2021 Disclosures: TBA
Dr. Matthias Gotberg and Dr. C. Michael Gibson Discuss: iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI November 4, 2021 Disclosures: TBD
Dr. Ajay Kirtane and Dr. Yazan Daaboul: RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration November 4, 2021 Disclosures: TBA
Dr. Haibo Jia, Jingbo Hou, and Dr. C. Michael Gibson Discuss: EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency November 4, 2021 Disclosures: TBA
Dr. Rafael Romaguera and Dr. C. Michael Gibson Discuss: SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes November 4, 2021 Disclosures: TBA
Dr. William Fearon and Dr. C. Michael Gibson Discuss: FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG November 4, 2021 Disclosures: TBA
